Clinical Trial Update: REWORD-HF REverse WOrsening Renal Function in Decompensated Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating whether REWORD-HF can reverse renal function worsening in acute decompensated heart failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure

Snippet

Sponsor: Niguarda Hospital | Conditions: Acute Decompensated Heart Failure | Phase 4 | Status: TERMINATED